JENNA MONGER: Open Payments
NPI 1528575560 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,710 in 106 payments from 19 companies in 2025. Trend: 2023 $2,332 · 2024 $1,906 · 2025 $1,710
Food & beverage: $1,697Education: $13
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 34 | $395 |
| PFIZER INC. | 11 | $207 |
| Novo Nordisk Inc | 10 | $191 |
| Amgen Inc. | 15 | $153 |
| Boston Scientific Corporation | 4 | $147 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $131 |
| Alnylam Pharmaceuticals Inc. | 5 | $91 |
| E.R. Squibb & Sons, L.L.C. | 4 | $87 |
| United Therapeutics Corporation | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
Products named: LEQVIO, Wegovy, REPATHA, WATCHMAN FLX, LifeVest, VYNDAQEL, ELIQUIS, AMVUTTRA.
Industry payments across MO — which companies pay providers there.
